Marvell (MRVL) Stock Downgraded as Concerns Grow Over Amazon Trainium Transitions
Marvell Technology, Inc.
Insider Monkey Blog
Eli Lilly’s Mounjaro Added to China’s National Health Insurance for Diabetes
Eli Lilly and Company (NYSE:LLY)’s popular drug Mounjaro will be added to China’s state-run health insurance program starting January 1, the National Healthcare Security Administration...
Guggenheim Highlights Growth Potential in Johnson & Johnson (JNJ), Maintains Buy
On December 5, Guggenheim boosted the firm’s price target on Johnson & Johnson (NYSE:JNJ) to $227 from $206 and maintained a Buy rating on the shares.
HSBC Upgrades AbbVie (ABBV) to Buy, Raises Price Target to $265
On December 10, HSBC increased its price target on AbbVie Inc. (NYSE:ABBV) from $225 to $265 and also upgraded the stock to Buy.
Morgan Stanley Raises CSX Price Target Amid Positive Freight Outlook
On December 8, Morgan Stanley raised its price target on CSX Corporation (NASDAQ:CSX) to $30 from $27 while maintaining an Equal Weight rating on the shares.
10 Data Center Cooling Companies to Invest In
The unprecedented data center demand driven by massive investments in AI infrastructure is well-documented.
Stifel Lifts IBM Price Target Following $11B Confluent Acquisition
On December 9, Stifel analyst David Grossman lifted his price target on International Business Machines Corporation (NYSE:IBM) to $325 from $295 after the company announced its...
Ecolab (ECL) Raises Quarterly Dividend 12%, Marking 34th Consecutive Increase
Ecolab Inc. (NYSE:ECL) announced on December 4 that it is raising its quarterly dividend by 12% to $0.73 per share.
Colgate-Palmolive (CL) Rated Outperform by RBC as Long-Term Growth Remains in Focus
On December 9, RBC Capital raised its rating on Colgate-Palmolive Company (NYSE:CL) to Outperform from Sector Perform while keeping the price target at $88.
Barclays Initiates Coverage on Cardinal Health (CAH) with Overweight Rating
Barclays analyst Glen Santangelo initiated coverage of Cardinal Health, Inc. (NYSE:CAH) on December 9, giving the stock an Overweight rating and a $243 price target.
BNP Paribas Exane Initiates Coverage on Dover Corporation (DOV) with Neutral Rating
In separate news, the company’s SWEP subsidiary introduced new products to address the rising demand in data center cooling and district energy systems.
Wells Fargo Notes Q4 2025 Pressure on AJG Margins, Trims Price Target
Wells Fargo analyst Elyse Greenspan trimmed her outlook on Arthur J. Gallagher & Co.
Lithium Deficit Could Boost Albemarle (ALB) Stock, Says UBS
UBS upgraded Albemarle Corporation (NYSE:ALB) to Buy from Neutral on December 5, and also raised its price target to $185 from $107.
Renewed Brand Focus Could Support Church & Dwight’s (CHD) EPS Growth, Says Argus
On December 4, Argus lowered its price target on Church & Dwight Co., Inc. (NYSE:CHD) to $102 from $110 but maintained a Buy rating on the shares.
Morgan Stanley Highlights Positive Outlook for Becton, Dickinson (BDX) and the MedTech Sector
On December 2, Morgan Stanley analyst Patrick Wood lifted the firm’s price target on Becton, Dickinson and Company (NYSE:BDX) to $210 from $197 and maintained an Overweight ...
Seaport Research Sees Brunswick Corporation (BC) Well-Positioned for Marine Market Recovery
On December 8, Seaport Research initiated its coverage on Brunswick Corporation (NYSE:BC) with a Buy rating and a $90 price target.
JPMorgan Trims Badger Meter (BMI) Price Target as Part of 2026 Outlook
On December 8, JPMorgan lowered the firm’s price target on Badger Meter, Inc. (NYSE:BMI) to $235 from $240 and maintained an Overweight rating on the shares.
15 Best Biotech Stocks to Buy According to Wall Street Analysts
The biotech sector has been a disaster for investors over the past five years going by a 14% decline compared to an 86% gain for the S&P 500 over the same period.
15 Best Long-Term Penny Stocks to Invest In
On December 10, Meghan Shue, Wilmington Trust chief investment strategist, appeared on CNBC’s ‘The Exchange’ to talk about the Federal Reserve meeting and the labor market...
10 Stocks Boasting the Biggest Gains; 4 Hit Record Highs
Ten stocks climbed higher on Wednesday, outperforming gains on Wall Street, as investors took heart from a combination of company catalysts and positive macroeconomic news.
Top 5 factors that shape a successful TGE in 2025
A token generation event (TGE) can define the early trajectory of a Web3 project, yet many assumptions about what drives success do not match real market behavior.
CentFX Announces Participation in iFX Expo 2026 as Silver Sponsor, Showcasing New Fintech Innovations
CentFX, a fast-growing provider of digital trading and financial technology solutions, is pleased to announce its participation in the upcoming iFX Expo, taking place on February...
Enterprise Products Partners (EPD) Price Target Updated by Analyst
Enterprise Products Partners L.P.
OGE Energy (OGE) Announces Dividend of $0.425 per Share
OGE Energy Corp. (NYSE:OGE), through its subsidiary, operates as an energy services provider in the United States.
Public Service Enterprise Group (PEG) – Among the Best Energy Stocks for a Retirement Portfolio
On November 20, Morgan Stanley lowered its price target on Public Service Enterprise Group Incorporated (NYSE:PEG) from $109 to $107, but kept an ‘Overweight’ rating on its...
Consolidated Edison (ED) Agrees to Divest Interest in Mountain Valley Pipeline
Consolidated Edison, Inc.
Canadian Natural Resources (CNQ) Announces Pricing of Medium-Term Notes
Canadian Natural Resources Limited (NYSE:CNQ) is a senior crude oil and natural gas production company, with continuing operations in its core areas located in Western Canada, ...
Phillips 66 (PSX) Sells Stake in Germany-Austria Retail Business
Phillips 66 (NYSE:PSX) announced on December 1 that it has closed the sale of a 65% stake in its Germany and Austria retail marketing business to a consortium owned by Stonepeak...
Entergy (ETR) Breaks Ground on Louisiana Power Plants
Entergy Corporation (NYSE:ETR) made headlines on December 1 when the company broke ground on two combined-cycle combustion turbine generation facilities in Louisiana.
Duke Energy (DUK) Rate Hikes Opposed by North Carolina Leaders
Duke Energy Corporation (NYSE:DUK) engages in the distribution of natural gas and energy-related services.
Chevron (CVX) Announces 2026 Capital Budget of $18 – $19 Billion
Chevron Corporation (NYSE:CVX) manufactures and sells a range of high-quality refined products, including gasoline, diesel, marine and aviation fuels, premium base oil, finished...
Exxon Mobil (XOM) Upgraded to Neutral by BNPP
Exxon Mobil Corporation (NYSE:XOM) received a boost on December 8 when BNPP analyst Lucas Herrmann upgraded the stock from ‘Underperform’ to ‘Neutral’, while giving it...
Clear Street Lifts Planet Labs (PL) Price Target, Maintains Buy Rating
Planet Labs (NYSE:PL) is one of the high short interest stocks to buy right now.
Jim Cramer Recently Commented on These 10 Stocks
“On a day where the Dow dipped 179 points, S&P declined 0.09%, Nasdaq actually inched up 0.13%, I want to talk to you about how the stock business works against you.
Hedge Fund and Insider Trading News: Bill Ackman, Eric Jackson, Point72 Asset Management, Soroban Capital Partners, L1 Capital, Msci Inc (MSCI), TransDigm Group Inc (TDG), and More
You may be concerned about the recent declines in AI stocks such as NVDA.
Citi Trends (CTRN): Analyst Sees Above-Average Incremental Margins
On December 2, the company posted earnings for the third quarter, reporting a revenue of more than $197 million, up 10% compared to the revenue over the same period last year ...
1-800-FLOWERS.COM (FLWS): CEO Charts Path Back to Growth
Latest reports indicate that Alexander Zelikovsky is poised to take over as the Chief Information Officer at 1-800-FLOWERS.COM, Inc.
KNOT Offshore Partners (KNOP): Alliance Global Sees Limited Upside
On December 8, Alliance Global downgraded KNOT Offshore Partners LP (NYSE:KNOP) to Neutral from Buy.
Jade Biosciences (JBIO): Analyst Lauds Entry into Market
On November 25, Clear Street analyst Kaveri Pohlman initiated coverage of Jade Biosciences, Inc. (NASDAQ:JBIO) stock with a Buy rating and $25 price target.
Omeros Corporation (OMER): Novo Nordisk Deal Creating Buzz
Latest reports show that Omeros Corporation (NASDAQ:OMER) has closed a deal worth around $2.1 billion with drug giant Novo Nordisk for the zaltenibart, a phase 2 asset of the ...
Pangaea Logistics Solutions (PANL): Third Quarter Earnings Beat Expectations
In earnings for the third quarter of 2025, Pangaea Logistics Solutions, Ltd. (NASDAQ:PANL) posted earnings per share of $0.17, beating estimates by $0.14.
Arq (ARQ): Clear Street Reiterates Buy Rating
In late November, Clear Street lowered the price target on Arq, Inc. (NASDAQ:ARQ) to $8 from $9 and kept a Buy rating on the shares.
Voyager Therapeutics (VYGR): Strong Q3 Prompts Bullish Coverage
On November 12, HC Wainwright lowered the price target on Voyager Therapeutics, Inc. (NASDAQ:VYGR) to $25 from $30 and kept a Buy rating on the shares.
Immutep Limited (IMMP): Firm Reports Positive Data from Trials
In mid-November, Immutep Limited (NASDAQ:IMMP) reported positive data from two clinical trials of its drug candidate eftilagimod alpha, or efti.
Tectonic Therapeutic (TECX): LifeSci Capital Reiterates Buy Rating
On November 18, LifeSci Capital reiterated a Buy rating on Tectonic Therapeutic, Inc. (NASDAQ:TECX) stock with a price target of $88. Tectonic Therapeutic, Inc.
Humacyte (HUMA): Benchmark Remains Bullish on Stock
In mid-November, Benchmark analyst Bruce Jackson maintained a Buy rating on Humacyte, Inc. (NASDAQ:HUMA) stock and set a price target of $11. Humacyte, Inc.
Mizuho Securities Reiterates Buy Rating on Adobe (ADBE) Ahead of Q4 Results With $450 PT
Meanwhile, on the previous day, TD Cowen’s Derrick Wood reaffirmed a “Hold” rating on Adobe Inc. (NASDAQ:ADBE) with a $420 price target.
Bernstein Reiterates “Buy” Rating on Oracle Corporation (ORCL) with $364 PT
Thanks to the company’s expanding AI footprint, Bernstein’s analyst Mark Moerdler reiterated a “Buy” rating on Oracle Corporation (NYSE:ORCL) on December 8, 2025, with...
Hedge Fund Resource Center
